OBJECTIVE: Li-Fraumeni syndrome (LFS) confers an increased risk of multiple types of cancer in both children and adults. Clinical genetic testing for deleterious germline p53 gene mutations can identify most LFS-affected families. We evaluated factors associated with cancer-specific distress and perceived self-efficacy in coping with a positive genetic test result among persons at risk of having deleterious p53 mutations. METHODS: One hundred thirty-five persons from 15 LFS-affected families were invited to take part in a study that offered p53 genetic counseling and testing and to complete psychosocial measures. RESULTS: Participants (n=92) were more likely to be younger and female than nonparticipants (n=43). In multivariate analyses, greater cancer-specific distress was associated with having a lower quality of life, a higher perceived risk of having a p53 mutation, no personal history of cancer and a greater number of first degree relatives (FDRs) affected with cancer. Lower perceived self-efficacy in coping with a positive test result was associated with greater cancer worry, higher decisional conflict about p53 testing and having no personal history of cancer. CONCLUSIONS: Individual perceptions about cancer risk and p53 genetic testing, as well as personal experience with FDRs' cancer diagnoses and deaths, should be addressed during the counseling and testing process for LFS-affected families.
OBJECTIVE: Li-Fraumeni syndrome (LFS) confers an increased risk of multiple types of cancer in both children and adults. Clinical genetic testing for deleterious germline p53 gene mutations can identify most LFS-affected families. We evaluated factors associated with cancer-specific distress and perceived self-efficacy in coping with a positive genetic test result among persons at risk of having deleterious p53 mutations. METHODS: One hundred thirty-five persons from 15 LFS-affected families were invited to take part in a study that offered p53 genetic counseling and testing and to complete psychosocial measures. RESULTS: Participants (n=92) were more likely to be younger and female than nonparticipants (n=43). In multivariate analyses, greater cancer-specific distress was associated with having a lower quality of life, a higher perceived risk of having a p53 mutation, no personal history of cancer and a greater number of first degree relatives (FDRs) affected with cancer. Lower perceived self-efficacy in coping with a positive test result was associated with greater cancer worry, higher decisional conflict about p53 testing and having no personal history of cancer. CONCLUSIONS: Individual perceptions about cancer risk and p53 genetic testing, as well as personal experience with FDRs' cancer diagnoses and deaths, should be addressed during the counseling and testing process for LFS-affected families.
Authors: G Bougeard; J M Limacher; C Martin; F Charbonnier; A Killian; O Delattre; M Longy; P Jonveaux; J P Fricker; D Stoppa-Lyonnet; J M Flaman; T Frébourg Journal: J Med Genet Date: 2001-04 Impact factor: 6.318
Authors: Debbie Saslow; Carla Boetes; Wylie Burke; Steven Harms; Martin O Leach; Constance D Lehman; Elizabeth Morris; Etta Pisano; Mitchell Schnall; Stephen Sener; Robert A Smith; Ellen Warner; Martin Yaffe; Kimberly S Andrews; Christy A Russell Journal: CA Cancer J Clin Date: 2007 Mar-Apr Impact factor: 508.702
Authors: A M Codori; G M Petersen; D L Miglioretti; E K Larkin; M T Bushey; C Young; J D Brensinger; K Johnson; J A Bacon; S V Booker Journal: Cancer Epidemiol Biomarkers Prev Date: 1999-04 Impact factor: 4.254
Authors: B J Henderson; S Tyndel; K Brain; A Clements; C Bankhead; J Austoker; E Watson; Stephen Duffy; Gareth Evans; Hilary Fielder; Jonathon Gray; James Mackay; Douglas Macmillan Journal: Psychooncology Date: 2008-01 Impact factor: 3.894
Authors: A Chompret; L Brugières; M Ronsin; M Gardes; F Dessarps-Freichey; A Abel; D Hua; L Ligot; M G Dondon; B Bressac-de Paillerets; T Frébourg; J Lemerle; C Bonaïti-Pellié; J Feunteun Journal: Br J Cancer Date: 2000-06 Impact factor: 7.640
Authors: Joel E Pacyna; Carmen Radecki Breitkopf; Sarah M Jenkins; Erica J Sutton; Caroline Horrow; Iftikhar J Kullo; Richard R Sharp Journal: J Med Genet Date: 2018-12-22 Impact factor: 6.318
Authors: June A Peters; Regina Kenen; Renee Bremer; Shannon Givens; Sharon A Savage; Phuong L Mai Journal: J Genet Couns Date: 2015-11-30 Impact factor: 2.537
Authors: Kate A McBride; Mandy L Ballinger; Timothy E Schlub; Mary-Anne Young; Martin H N Tattersall; Judy Kirk; Ros Eeles; Emma Killick; Leslie G Walker; Sue Shanley; David M Thomas; Gillian Mitchell Journal: Fam Cancer Date: 2017-07 Impact factor: 2.375
Authors: J J Bakhuizen; F B Hogervorst; M E Velthuizen; M W Ruijs; K van Engelen; T A van Os; J J Gille; M Collée; A M van den Ouweland; C J van Asperen; C M Kets; A R Mensenkamp; E M Leter; M J Blok; M M de Jong; M G Ausems Journal: Fam Cancer Date: 2019-04 Impact factor: 2.375
Authors: Shoshana Shiloh; Christopher H Wade; J Scott Roberts; Sharon Hensley Alford; Barbara B Biesecker Journal: Med Decis Making Date: 2012-11-05 Impact factor: 2.583
Authors: Allison Werner-Lin; Jennifer L Young; Catherine Wilsnack; Shana L Merrill; Victoria Groner; Mark H Greene; Payal P Khincha Journal: Fam Cancer Date: 2020-07 Impact factor: 2.375
Authors: Jessica Ross; Jasmina Bojadzieva; Susan Peterson; Sarah Jane Noblin; Rebecca Yzquierdo; Martha Askins; Louise Strong Journal: Genet Med Date: 2017-03-16 Impact factor: 8.822